Ads
related to: moderate to poorly differentiated adenocarcinoma in pancreas- Find A Treatment Center
Use This Treatment Site Locator
To Find Nearest Treatment Center.
- Treatment Safety
Read The Rx Safety Profile.
Visit The Website To Learn More.
- Clinical Data
Access Clinical Trial Data.
View Efficacy Information.
- FDA-Approved Treatment
Regimen For Somatostatin Receptor-
Positive GEP-NETs. HCPs Resources.
- Find A Treatment Center
Search results
Results From The WOW.Com Content Network
The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, [11] and the term "pancreatic cancer" is sometimes used to refer only to that type. [10] These adenocarcinomas start within the part of the pancreas that makes digestive enzymes . [ 10 ]
A pancreatic tumor is an abnormal growth in the pancreas. [1] In adults, almost 90% are pancreatic cancer and a few are benign. [1] Pancreatic tumors are rare in children. [1] Classification is based on cellular differentiation (ductal, acinar, neuroendocrine, other) and gross appearance (intraductal, cystic, solid). [1]
Well-differentiated adenocarcinomas tend to resemble the glandular tissue that they are derived from, while poorly differentiated adenocarcinomas may not. By staining the cells from a biopsy , a pathologist can determine whether the tumor is an adenocarcinoma or some other type of cancer.
The majority of cancers of unknown primary, about 90%, are adenocarcinomas, with 60% appearing as moderately to well-differentiated adenocarcinoma, while about 30% are poorly differentiated adenocarcinoma. The term adenocarcinoma refers to cancer that begins in the cells in glandular structures in the lining or covering of certain organs in the ...
G (1–4): the grade of the cancer cells (i.e. they are "low grade" if they appear similar to normal cells, and "high grade" if they appear poorly differentiated) S (0–3): elevation of serum tumor markers; R (0–2): the completeness of the operation (resection-boundaries free of cancer cells or not) Pn (0–1): invasion into adjunct nerves
Lower Gleason scores describe well-differentiated less aggressive tumors. Other systems include the Bloom-Richardson grading system for breast cancer and the Fuhrman system for kidney cancer . Invasive-front grading is useful as well in oral squamous cell carcinoma.